Gum disease study targets immune pathway for future treatments
NCT ID NCT07536204
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This observational study at the University of Chile is examining whether a specific immune pathway (JAK1/2) is overactive in people with periodontitis, a common gum disease. Researchers will compare gum tissue from 30 healthy adults and those with inflamed gums to measure pathway activation. The goal is to understand the disease better and identify potential targets for new treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If this study shows the JAK1/2 pathway is overactive in periodontitis, it could point toward new drug targets for treating gum disease.
- What could go wrong
- This is a small, early observational study (30 participants) that only looks at tissue samples. It does not test any treatment, so any potential therapy is years away and may not work.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GINGIVAL DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of Dentistry, University of Chile
RECRUITINGSantiago, Metropolitan Region, Chile
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Nature's mouthwash: could tea tree oil and thyme tame gum disease?
- Blood-Derived clot may regrow bone in gum disease
- Can gum disease be stopped by targeting these genes?
- Could saliva hold the key to understanding gum disease?
- Can a gentler Deep-Clean beat standard gum therapy?
- Could a toothpaste ingredient reshape the microbes behind gum disease?